z-logo
Premium
Comment on a paper by Dupoiron et al. “A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release ( PR ) oxycodone‐ naloxone (up to 160/80 mg daily) versus oxycodone PR ”
Author(s) -
Patel Joanne,
Martin Jennifer H.,
Lucas Catherine J.
Publication year - 2017
Publication title -
european journal of pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.305
H-Index - 109
eISSN - 1532-2149
pISSN - 1090-3801
DOI - 10.1002/ejp.1098
Subject(s) - oxycodone , (+) naloxone , medicine , analgesic , anesthesia , randomized controlled trial , immediate release , morphine , opioid , pharmacology , receptor

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom